mHealth Research Digest with Tim Bredrup

In an attempt to understand the barriers and motivational factors of telemedicine in acute care units, C3O Medical Group (Ojai, California) recently conducted a survey of emergency and critical care remote presence telemedicine users to find out what motivates and also impedes the use of robotic telemedicine (RTM) programs.

E-mails were sent to 483 individuals from 63 different healthcare organizations across North America and Europe inviting them to participate in the web-based survey. The 96 question survey addressed user familiarity as well as conceptual and practical issues currently facing telemedicine adoption.

In total, 106 surveys were completed with an individual response rate of 21.9% and an institutional response rate of 60.3%.

“More than two-thirds of the respondents were physicians who participated in active RTM programs,” C3O explained. “Across seven different topics related to barriers to implementing RTM, the majority of all respondents indicated that cultural issues did not constitute meaningful hurdles, technological matters were generally favorable, and that most personnel were agreeable to both achieving the buy-in to start an RTM program and to maintaining RTM once started.”

The researchers go on to say:

“survey respondents proclaimed that RTM’s success was still hampered by licensing, credentialing, and malpractice protection, as well as costs, billing, and reimbursement issues. Achieving immediate patient access, overcoming service gaps, improving quality, providing clinical support, maintaining patient satisfaction, and adherence to practice guidelines were viewed as significant motives for RTM implementation.”

The study indicated that the leading applications of RTM involved emergency response and consultation. It was also concluded that patients, physicians, nurses, and hospital executives were not seen as barriers while the main factors impeding progress have to do with licensing, costs for technology and RTM reimbursement.

Authors:

Rogove HJ, McArthur D, Demaerschalk BM, Vespa PM.

C3O Medical Group – Ojai, California.

Original Abstract:

PubMed